Skip to main content
Fig. 1 | Journal of Neuroinflammation

Fig. 1

From: Decrease in naturally occurring antibodies against epitopes of Alzheimer’s disease (AD) risk gene products is associated with cognitive decline in AD

Fig. 1

Plasma levels of NAbs in the CN, MCI and AD groups. Plasma levels of NAbs in each group were analyzed using one-way analysis of variance (ANOVA). N.S. denotes no statistical difference. *Denotes nominal significance only at P < 0.05. ***Denotes significance after Bonferroni correction at P < 0.002 [α = 0.05/number of tests (28), 0.002]. NAbs natural antibodies, AD Alzheimer’s disease, MCI mild cognitive impairment, CN cognitively normal controls

Back to article page

Journal of Neuroinflammation

ISSN: 1742-2094